Key points are not available for this paper at this time.
These findings demonstrate that ras mutations are a marker for aggressive cancer behavior and indicate a possible role of ras genotyping to identify thyroid carcinoma subsets associated with poor prognosis.
García‐Rostán et al. (Thu,) studied this question.